CytoMed Therapeutics Limited

NasdaqCM:GDTC Stock Report

Market Cap: US$25.4m

CytoMed Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of GDTC?
Owner TypeNumber of SharesOwnership Percentage
Institutions5,2380.0454%
Public Companies1,336,92311.6%
Individual Insiders2,168,67518.8%
General Public3,540,87330.7%
Private Companies4,488,29138.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 69.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
38.9%
Glorious Finance Ltd.
4,488,291US$9.9m0%no data
11.6%
mDR Limited
1,336,923US$2.9m0%no data
7.66%
Shu Wang
883,858US$1.9m0%no data
5.18%
Chee Kong Choo
598,015US$1.3m0%no data
5.11%
Jieming Zeng
589,239US$1.3m0%no data
0.8%
Tien Wee Luk
92,563US$203.6k0%no data
0.045%
Geode Capital Management, LLC
5,177US$11.4k9.85%no data
0.043%
Wee Kiat Tan
5,000US$11.0k0%no data
0.00053%
UBS Asset Management AG
61US$134.60%no data